Search

Christopher Upton

Examiner (ID: 3762, Phone: (571)272-1169 , Office: P/1778 )

Most Active Art Unit
1778
Art Unit(s)
1797, 1306, 1308, 1776, 1778, 1724
Total Applications
3146
Issued Applications
2580
Pending Applications
123
Abandoned Applications
451

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7263189 [patent_doc_number] => 20040261139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Androgen receptor knock-out transgenic animals' [patent_app_type] => new [patent_app_number] => 10/484950 [patent_app_country] => US [patent_app_date] => 2004-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 33561 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20040261139.pdf [firstpage_image] =>[orig_patent_app_number] => 10484950 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/484950
Androgen receptor knock-out transgenic animals Aug 15, 2004 Abandoned
Array ( [id] => 7347864 [patent_doc_number] => 20040248140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Nucleotidic sequences having activity of controlling translation efficiency and utilization thereof' [patent_app_type] => new [patent_app_number] => 10/500346 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10887 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248140.pdf [firstpage_image] =>[orig_patent_app_number] => 10500346 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/500346
Nucleotidic sequences having activity of controlling translation efficiency and utilization thereof Jul 28, 2004 Abandoned
Array ( [id] => 7060560 [patent_doc_number] => 20050002920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Antigen presenting cells, method for their preparation and their use for cancer vaccines' [patent_app_type] => utility [patent_app_number] => 10/898187 [patent_app_country] => US [patent_app_date] => 2004-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9963 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002920.pdf [firstpage_image] =>[orig_patent_app_number] => 10898187 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/898187
Antigen presenting cells, method for their preparation and their use for cancer vaccines Jul 25, 2004 Abandoned
Array ( [id] => 7328328 [patent_doc_number] => 20040253631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Recombinational cloning using nucleic acids having recombination sites' [patent_app_type] => new [patent_app_number] => 10/893235 [patent_app_country] => US [patent_app_date] => 2004-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 29689 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253631.pdf [firstpage_image] =>[orig_patent_app_number] => 10893235 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/893235
Recombinational cloning using nucleic acids having recombination sites Jul 18, 2004 Issued
Array ( [id] => 7322078 [patent_doc_number] => 20040226052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Methods of producing a target molecule in a transgenic animal and purification of the target molecule' [patent_app_type] => new [patent_app_number] => 10/862951 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13761 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20040226052.pdf [firstpage_image] =>[orig_patent_app_number] => 10862951 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/862951
Methods of producing a target molecule in a transgenic animal and purification of the target molecule Jun 7, 2004 Abandoned
Array ( [id] => 7322080 [patent_doc_number] => 20040226053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Methods of producing a target molecule in a transgenic animal and purification of the target molecule' [patent_app_type] => new [patent_app_number] => 10/863101 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13763 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20040226053.pdf [firstpage_image] =>[orig_patent_app_number] => 10863101 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/863101
Methods of producing a target molecule in a transgenic animal and purification of the target molecule Jun 7, 2004 Abandoned
Array ( [id] => 585762 [patent_doc_number] => 07442688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-28 [patent_title] => 'Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation' [patent_app_type] => utility [patent_app_number] => 10/860373 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 32408 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/442/07442688.pdf [firstpage_image] =>[orig_patent_app_number] => 10860373 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/860373
Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation Jun 2, 2004 Issued
Array ( [id] => 7277676 [patent_doc_number] => 20040237127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation' [patent_app_type] => new [patent_app_number] => 10/860724 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32915 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20040237127.pdf [firstpage_image] =>[orig_patent_app_number] => 10860724 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/860724
Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation Jun 2, 2004 Issued
Array ( [id] => 7256211 [patent_doc_number] => 20040259829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Compositions and methods for sensitizing and inhibiting growth of human tumor cells' [patent_app_type] => new [patent_app_number] => 10/858271 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13145 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259829.pdf [firstpage_image] =>[orig_patent_app_number] => 10858271 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/858271
Compositions and methods for sensitizing and inhibiting growth of human tumor cells May 31, 2004 Issued
Array ( [id] => 7116617 [patent_doc_number] => 20050069918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'JAB1 as a prognostic marker and a therapeutic target for human cancer' [patent_app_type] => utility [patent_app_number] => 10/858869 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 38552 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069918.pdf [firstpage_image] =>[orig_patent_app_number] => 10858869 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/858869
JAB1 as a prognostic marker and a therapeutic target for human cancer May 31, 2004 Abandoned
Array ( [id] => 7195758 [patent_doc_number] => 20050164218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Gene expression markers for response to EGFR inhibitor drugs' [patent_app_type] => utility [patent_app_number] => 10/857715 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11953 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164218.pdf [firstpage_image] =>[orig_patent_app_number] => 10857715 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/857715
Gene expression markers for response to EGFR inhibitor drugs May 27, 2004 Abandoned
Array ( [id] => 7432642 [patent_doc_number] => 20040209840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Manipulation of arterial-venous identity' [patent_app_type] => new [patent_app_number] => 10/848191 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5023 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209840.pdf [firstpage_image] =>[orig_patent_app_number] => 10848191 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/848191
Manipulation of arterial-venous identity May 17, 2004 Abandoned
Array ( [id] => 7088954 [patent_doc_number] => 20050009067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Expression profile of pancreatic cancer' [patent_app_type] => utility [patent_app_number] => 10/848259 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 30895 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009067.pdf [firstpage_image] =>[orig_patent_app_number] => 10848259 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/848259
Expression profile of pancreatic cancer May 17, 2004 Abandoned
Array ( [id] => 5642633 [patent_doc_number] => 20060281088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Markers for lxr activation' [patent_app_type] => utility [patent_app_number] => 10/557720 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6876 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281088.pdf [firstpage_image] =>[orig_patent_app_number] => 10557720 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/557720
Markers for lxr activation May 13, 2004 Abandoned
Array ( [id] => 7061150 [patent_doc_number] => 20050003511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'New yeast-bacteria shuttle vector' [patent_app_type] => utility [patent_app_number] => 10/843542 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6803 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003511.pdf [firstpage_image] =>[orig_patent_app_number] => 10843542 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/843542
New yeast-bacteria shuttle vector May 9, 2004 Abandoned
Array ( [id] => 7183312 [patent_doc_number] => 20040203077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Method and kit for quantitation of polypeptides' [patent_app_type] => new [patent_app_number] => 10/473043 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4335 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203077.pdf [firstpage_image] =>[orig_patent_app_number] => 10473043 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/473043
Method and kit for quantitation of polypeptides May 3, 2004 Abandoned
Array ( [id] => 7206382 [patent_doc_number] => 20050043260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Wnt as a factor for cardiac myogenesis' [patent_app_type] => utility [patent_app_number] => 10/828669 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18389 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043260.pdf [firstpage_image] =>[orig_patent_app_number] => 10828669 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/828669
Wnt as a factor for cardiac myogenesis Apr 20, 2004 Abandoned
Array ( [id] => 5216020 [patent_doc_number] => 20070105101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Gene expression associated with osteobla st differentiation' [patent_app_type] => utility [patent_app_number] => 10/552319 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23561 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105101.pdf [firstpage_image] =>[orig_patent_app_number] => 10552319 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/552319
Gene expression associated with osteobla st differentiation Apr 4, 2004 Abandoned
Array ( [id] => 5188402 [patent_doc_number] => 20070166710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Methods for inhibiting adipogenesis and for treating type 2 diabetes' [patent_app_type] => utility [patent_app_number] => 10/551392 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 21669 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166710.pdf [firstpage_image] =>[orig_patent_app_number] => 10551392 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/551392
Methods for inhibiting adipogenesis and for treating type 2 diabetes Mar 30, 2004 Abandoned
Array ( [id] => 7672949 [patent_doc_number] => 20040180830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder' [patent_app_type] => new [patent_app_number] => 10/806515 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25735 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180830.pdf [firstpage_image] =>[orig_patent_app_number] => 10806515 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/806515
Methods and compositions for preventing and treating male erectile dysfunction Mar 21, 2004 Issued
Menu